纳米粒子方法用于操纵细胞因子的输送和中和
Rui Wang1, Luke J Kubiatowicz1, Runhe Zhang1
1Aiiso Yufeng Li Family Department of Chemical and Nano Engineering, Shu and K.C. Chien and Peter Farrell Collaboratory, University of California San Diego, San Diego, United States.
Frontiers in immunology
|June 25, 2025
概括
纳米技术通过改善输送和中和来增强细胞因子疗法. 本综述探讨了纳米粒子平台用于治疗免疫疾病,克服毒性和药物动力学挑战,以获得更好的临床结果.
科学领域:
- 免疫学和纳米医学
- 细胞因子和纳米颗粒的治疗应用.
背景情况:
- 细胞因子是免疫反应,炎症和耐受性的关键调节者.
- 基于细胞因子的疗法对癌症,感染和自身免疫性疾病有前途,但面临毒性和药理动力学差异等挑战.
- 纳米技术提供了改善细胞因子递送和中和的解决方案.
研究的目的:
- 审查基于纳米粒子的策略,以增强细胞因子的输送和中和.
- 为突出纳米粒子平台对细胞因子操纵的进步.
- 讨论纳米粒子-细胞因子治疗的临床发展和未来的挑战.
主要方法:
- 对纳米粒子系统的审查,用于封装蛋白质,DNA或mRNA的有效载荷,用于细胞因子的输送.
- 对纳米粒子平台进行细胞因子中和的分析,包括抗体复合物和细胞膜涂层.
- 检查纳米粒子介导细胞因子疗法的临床进展和挑战.
主要成果:
- 纳米粒子平台可以有效地封装各种有效载荷,以提供有针对性的细胞因子.
- 新型纳米粒子设计促进了有效的细胞因子中和,减轻了不良影响.
- 新兴的临床数据显示,纳米粒子增强型细胞因子疗法具有前景.
结论:
- 基于纳米粒子的方法显著改善了细胞因子的输送和中和,解决了传统疗法的关键局限性.
- 进一步的研究和临床开发对于充分利用纳米粒子-细胞因子策略的治疗潜力至关重要.
- 克服剩余的挑战将为免疫相关疾病的先进治疗铺平道路.
更多相关视频
09:36Polyethyleneimine-coated Iron Oxide Nanoparticles as a Vehicle for the Delivery of Small Interfering RNA to Macrophages In Vitro and In Vivo
Published on: February 5, 2019
8.9K
09:43Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
Published on: March 8, 2024
1.9K
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
167
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
167
Site-Targeted Drug Delivery Systems: Polymeric Carriers
167
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
167
